These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 19177750)
1. [Structure and molecular mechanisms of infection and replication of HIV]. Sato H; Ode H; Motomura K; Yokoyama M Nihon Rinsho; 2009 Jan; 67(1):37-42. PubMed ID: 19177750 [TBL] [Abstract][Full Text] [Related]
2. HIV virology and pathogenetic mechanisms of infection: a brief overview. Fanales-Belasio E; Raimondo M; Suligoi B; Buttò S Ann Ist Super Sanita; 2010; 46(1):5-14. PubMed ID: 20348614 [TBL] [Abstract][Full Text] [Related]
3. Defining and solving the essential protein-protein interactions in HIV infection. Finzi D; Dieffenbach CW; Basavappa R J Struct Biol; 2007 May; 158(2):148-55. PubMed ID: 17175170 [TBL] [Abstract][Full Text] [Related]
4. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications]. Azevedo-Pereira JM; Santos-Costa Q Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693 [TBL] [Abstract][Full Text] [Related]
5. [Etiopathogenesis of HIV infection]. Pérez Alvarez L Arch Neurobiol (Madr); 1989; 52 Suppl 1():17-22. PubMed ID: 2700293 [TBL] [Abstract][Full Text] [Related]
6. HIV accessory genes Vif and Vpu. Strebel K Adv Pharmacol; 2007; 55():199-232. PubMed ID: 17586316 [No Abstract] [Full Text] [Related]
7. Regulated superinfection may help HIV adaptation on rugged landscape. Leontiev V; Hadany L Infect Genet Evol; 2010 May; 10(4):505-10. PubMed ID: 20226882 [TBL] [Abstract][Full Text] [Related]
8. Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection. Kwa D; Vingerhoed J; Boeser B; Schuitemaker H J Infect Dis; 2003 May; 187(9):1397-403. PubMed ID: 12717620 [TBL] [Abstract][Full Text] [Related]
12. [New virological data: replication and persistence of the human immunodeficiency virus]. Clavel F Rev Prat; 1992 Jan; 42(2):142-7. PubMed ID: 1348868 [TBL] [Abstract][Full Text] [Related]
13. HIV. Escape artist par excellence. Cohen J Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245 [No Abstract] [Full Text] [Related]
14. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Peterlin BM; Trono D Nat Rev Immunol; 2003 Feb; 3(2):97-107. PubMed ID: 12563294 [TBL] [Abstract][Full Text] [Related]
15. The scoop on HIV mutations. Coffin JM J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):45. PubMed ID: 11363749 [TBL] [Abstract][Full Text] [Related]
16. Principles of current adult HIV pharmacotherapy. Landor M Ann Allergy Asthma Immunol; 1998 May; 80(5):363-7; quiz 367-8. PubMed ID: 9609603 [TBL] [Abstract][Full Text] [Related]
17. Functions of the HIV-1 matrix protein p17. Fiorentini S; Marini E; Caracciolo S; Caruso A New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119 [TBL] [Abstract][Full Text] [Related]
19. [Antiviral strategies in the replication of human immunodeficiency virus]. Wainberg MA; Bour S; Geleziunas R; Bentwich Z Union Med Can; 1992; 121(5):307-9, 312-4. PubMed ID: 1279875 [TBL] [Abstract][Full Text] [Related]
20. Managing HIV. Part 3: Mechanisms of disease. 3.1 Structure and function of HIV. Cunningham AL; Dwyer DE; Mills J; Montagnier L Med J Aust; 1996 Feb; 164(3):161-5. PubMed ID: 8628136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]